The global diagnostic imaging market is anticipated to grow significantly at 6.8% CAGR during 2021-2027 owing to the increasing prevalence of diagnostic imaging centers, robust growth in healthcare expenditure, mounting demand for diagnostic imaging procedures, increasing incidences of chronic diseases, technological development in diagnostic imaging, and increase in the geriatric population. Furthermore, the development in 3D imaging technology provided advancement in computer-aided detection (CAD), favorable regulatory scenario for medical imaging modalities for effective patient management, increasing usage of medical imaging in digital health will propel the growth in the global diagnostic imaging market. Multimodal/ Hybrid Imaging Systems are considered as the future of diagnostic imaging devices by the industry players and can be installed at less space and investment. Moreover, it helps in achieving precision diagnostics.

Carestream had a partnership with Ziehm Imaging for the distribution of the Ziehm Vision RFD C- arm so as to increase the revenue.

The COVID-19 pandemic has led to the increased adoption of diagnostic procedures for infected and critical patients has resulted in substantial demand for the diagnostics market but the decrease in trading activity has affected the product sales. In addition, the decline in the number of patients visiting the hospitals resulting in a decrease in demand for MRI and molecular imaging equipment has impacted the diagnostics imaging market.

Request to get a free sample copy at https://www.vynzresearch.com/healthcare/diagnostic-imaging-market/request-sample

Based on product, CT Scanners dominate the diagnostic imaging market owing to the rising demand for early and precise diagnostics, increasing adoption of CT scanners by hospitals and diagnostic centers globally. Moreover, CT Scanners have a steady increase in demand as the chest plays a significant role in diagnosing COVID-19 infection, and monitoring COVID-19 infection is done via CT scan.

North America dominates the global diagnostic imaging market owing to the rising geriatric population suffering from chronic diseases, ease in accessibility of diagnostic imaging modalities, technological development. According to the National Brain Tumor Society, in 2020, about 7,00,000 people in the US are having a brain tumor, and approx. 87,000 are anticipated to be diagnosed with brain tumors resulting in the growth of the diagnostic imaging market in the region.

Some of the recent developments include Koninklijke Philips N.V. has launched the spectral detector-based Spectral Computed Tomography (CT) 7500 solution for precision diagnosis, Siemens Healthineers (Germany), received FDA clearance for the Biograph Vision Quadra, a PET/CT scanner for clinical use, and translational research.

The prominent players in the global diagnostic imaging industry include GE Healthcare, Hitachi Ltd., Siemens AG, Samsung Medison, Carestream Health, Koninklijke Philips N.V., Esaote S.P.A, Shimadzu Corporation, Toshiba Corporation, and Fujifilm Holdings Corporation.

Source; VynZ Research